Scoop has an Ethical Paywall
Kick-off Global movement to bust Abbott's monopoly on AID
Today Abbott Laboratories became the target of a
multi-country protest because of its monopoly of the most
important HIV/AIDs drug ever made, Kaletra, is not available
to the people who need it most.
This unique medicine not only prevents HIV/AIDs but it is 96% successful in the treatment of AIDS. However, Abbott keeps the price of this product so high that it is killing people by keeping the medicine out of reach for the most severely affected populations. We are calling for generic competition for this critical AIDs drug immediately.
According to a policy speech made two days ago by U.S. Secretary of State Hillary Clinton, it’s possible for the world to have an “AIDs-free generation” for the first time since the disease was identified. Without global access to this medicine, that statement is nothing but a pipe dream.
Please visit http://www.citizen.org/Kaletra-campaign
for all the news and FAQs on our call for generic
competition of Kaletra.
ENDS
Sonali Kolhatkar, IMI: What Is Our Collective Solution To Health Injustice?
Cook Islands Investment Incorporation: Government Partners With Communities To Improve Safety Shelters
Richard D. Wolff, IMI: Political Economy Contradictions As We Lurch Into 2025
People with Disability Australia - PWDA: CMHA And PWDA Demand Justice And Urgent Reform Following Death Of Simon Cartwright At Silverwater Jail
UNICEF Aotearoa NZ: Vanuatu Quake - UNICEF Aotearoa Launches Urgent Fundraising Appeal For 40,000 Children In Need
New Zealand Defence Force: Surveillance, Aid, Responders And Evacuees Covered By RNZAF Vanuatu Flights